The Society for Immunotherapy of Cancer Consensus Statement on Immunotherapy for the Treatment of Hematologic Malignancies: Multiple Myeloma, Lymphoma, and Acute Leukemia

This is a clinical practice guideline for patients with hematologic malignancies. The guideline specifically examines immunotherapy for the treatment of multiple myeloma, lymphoma, and acute leukemia. Topics of interest include patient selection, toxicity management, clinical endpoints, and the sequencing or combination of therapies.